HUTCHMED (China) Limited
HCM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £630 | £838 | £426 | £356 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | £349 | £686 | £311 | £258 |
| Gross Profit | £281 | £152 | £115 | £98 |
| % Margin | 44.6% | 18.1% | 27% | 27.5% |
| R&D Expenses | £212 | £302 | £268 | £207 |
| G&A Expenses | £64 | £80 | £92 | £89 |
| SG&A Expenses | £113 | £133 | £136 | £127 |
| Sales & Mktg Exp. | £49 | £53 | £44 | £38 |
| Other Operating Expenses | -£3 | -£302 | £119 | £92 |
| Operating Expenses | £322 | £133 | £523 | £426 |
| Operating Income | -£41 | £18 | -£408 | -£328 |
| % Margin | -6.4% | 2.2% | -95.6% | -92.2% |
| Other Income/Exp. Net | £0 | £87 | £47 | £173 |
| Pre-Tax Income | £45 | £106 | -£361 | -£155 |
| Tax Expense | £7 | £5 | -£0 | £12 |
| Net Income | £38 | £101 | -£361 | -£195 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.044 | 0.12 | -0.43 | -0.25 |
| % Growth | -63.4% | 127.9% | -72% | – |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.25 |
| Weighted Avg Shares Out | 860 | 850 | 793 | 793 |
| Weighted Avg Shares Out Dil | 873 | 869 | 793 | 793 |
| Supplemental Information | – | – | – | – |
| Interest Income | £40 | £36 | £10 | £2 |
| Interest Expense | £3 | £1 | £1 | £1 |
| Depreciation & Amortization | £12 | £8 | £9 | £7 |
| EBITDA | £14 | £67 | -£401 | -£321 |
| % Margin | 2.2% | 8% | -94.1% | -90.2% |